(Q34049234)

English

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer

scientific article

Statements

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer (English)
Bryan T J Hennessy
Kirsten M Timms
Mark S Carey
Alexander Gutin
Larissa A Meyer
Darl D Flake
Victor Abkevich
Jennifer Potter
Dmitry Pruss
Karen Smith McCune
Maurie Markman
Russell R Broaddus
Jerry S Lanchbury
3570-3576

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit